AERx® IDMS (inhaled insulin)
AERx® insulin Diabetes Management System (iDMS) is an electronic delivery system for inhalation of insulin. Development is driven in close cooperation between Novo Nordisk Delivery Technologies in Hayward, CA and Novo Nordisk Global Development.
AERx® is designed to provide improved convenience for healthcare professionals and patients, through unique features such as 1-unit increments, dose linearity, dial-a-dose and an interactive patient guidance system. A two-year phase 3 safety study on AERx® is ongoing. *AERx is a registered trademark of Aradigm Corporation, US.
